HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 5 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $599 | -4.5% | 7 | 0.0% | 0.00% | – |
| Q3 2023 | $627 | -38.6% | 7 | -41.7% | 0.00% | – |
| Q2 2023 | $1,022 | +37.2% | 12 | +33.3% | 0.00% | – |
| Q1 2023 | $745 | +5.2% | 9 | 0.0% | 0.00% | – |
| Q4 2022 | $708 | -29.2% | 9 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 9 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 9 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 9 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 9 | -55.0% | 0.00% | -100.0% |
| Q1 2020 | $1,000 | -50.0% | 20 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | 0.0% | 20 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | -33.3% | 20 | -31.0% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | -88.5% | 29 | -82.1% | 0.00% | -83.3% |
| Q1 2019 | $26,000 | -31.6% | 162 | -57.5% | 0.01% | -66.7% |
| Q4 2018 | $38,000 | -13.6% | 381 | -2.6% | 0.02% | 0.0% |
| Q3 2018 | $44,000 | +15.8% | 391 | -9.7% | 0.02% | +12.5% |
| Q2 2018 | $38,000 | +15.2% | 433 | -4.8% | 0.02% | +14.3% |
| Q1 2018 | $33,000 | +26.9% | 455 | -1.3% | 0.01% | +27.3% |
| Q4 2017 | $26,000 | +85.7% | 461 | +43.2% | 0.01% | +37.5% |
| Q3 2017 | $14,000 | +16.7% | 322 | +3.5% | 0.01% | +14.3% |
| Q2 2017 | $12,000 | +33.3% | 311 | +36.4% | 0.01% | +40.0% |
| Q1 2017 | $9,000 | 0.0% | 228 | -3.0% | 0.01% | 0.0% |
| Q4 2016 | $9,000 | -18.2% | 235 | -25.9% | 0.01% | -16.7% |
| Q3 2016 | $11,000 | +175.0% | 317 | +91.0% | 0.01% | +200.0% |
| Q2 2016 | $4,000 | -55.6% | 166 | -37.8% | 0.00% | -60.0% |
| Q1 2016 | $9,000 | +12.5% | 267 | -4.0% | 0.01% | 0.0% |
| Q4 2015 | $8,000 | – | 278 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |